SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $478 | -84.6% | 2,600 | 0.0% | 0.00% | – |
Q2 2023 | $3,107 | +72.9% | 2,600 | 0.0% | 0.00% | – |
Q1 2023 | $1,797 | +1.8% | 2,600 | 0.0% | 0.00% | – |
Q4 2022 | $1,765 | -96.7% | 2,600 | -88.5% | 0.00% | -100.0% |
Q3 2021 | $54,000 | -14.3% | 22,600 | -4.2% | 0.01% | -16.7% |
Q2 2021 | $63,000 | -45.2% | 23,600 | +2.6% | 0.01% | -45.5% |
Q1 2021 | $115,000 | – | 23,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Uniplan Investment Counsel, Inc. | 2,033,020 | $1,904,000 | 0.13% |
1492 Capital Management LLC | 150,000 | $141,000 | 0.11% |
Spark Investment Management LLC | 13,100 | $12,000 | 0.02% |
ARDSLEY ADVISORY PARTNERS LP | 80,000 | $75,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 27,437 | $26,000 | 0.00% |
WealthPLAN Partners, LLC | 20,000 | $18,000 | 0.00% |
CIBC WORLD MARKET INC. | 500,000 | $468,000 | 0.00% |
CAPITAL COUNSEL LLC/NY | 10,000 | $9,000 | 0.00% |
J.W. COLE ADVISORS, INC. | 10,000 | $9,000 | 0.00% |
Renaissance Technologies | 591,086 | $554,000 | 0.00% |